Journal Mobile Options
Table of Contents
Vol. 45, No. 3, 1988
Issue release date: 1988
Oncology 1988;45:137–140

Early Results on Modification of Combined Modality Treatment (Chemotherapy and Surgery) for Testicular Cancer

Madej G. · Siedlecki P.
aUnit of Chemotherapy and bDepartment of Chemotherapy, Maria Sklodowska-Curie Memorial Institute of Oncology, Warsaw, Poland

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Early results of modified combined modality of treatment (chemotherapy and surgery) of 58 patients with nonseminoma of the testis treated in the Institute of Oncology in Warsaw from January 1983 to December 1985 indicated a significant improvement in comparison to the preceding period of time (70 vs. 80% probability of 5-year survival). The treatment was well tolerated and no patient refused therapy. The authors suggest that this improvement can depend on using a more effective program of chemotherapy in half the patients (VAB-6) and the majority of less advanced treated cases than in the last period. This problem will be the subject of further investigation.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00